Do Script Concordance Tests Correlate With Family Medicine Standardized Tests and Failing Rotation Grades?
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03938610 |
Recruitment Status :
Recruiting
First Posted : May 6, 2019
Last Update Posted : July 23, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Knowledge, Attitudes, Practice |
This study is a longitudinal observation study. A panel of experts (numbering 15-20) consisting of Family Medicine attendings who have been out of residency greater than 3 years will complete the SCT. They will be provided an Informational Consent. Their willingness to be a panel member is their implied consent to be part of the research study.
The basic idea behind SCT is to compare residents' performance with a group of persons who are representatives of the profession (or the specialty) to which they wish to belong. Therefore, panels are made up of physicians with good overall clinical experience in the field rather than experts from narrow parts of the field. Panel composition also depends on the assessment goal.
This study will determine if a Script Concordance Test (SCT) correlates with Family Medicine In Training Exam (ITE) scores, American Board of Family Medicine (ABFM) certification exam scores, Accreditation Council for Graduate Medical Education (ACGME) medical knowledge and patient care milestones, and failing family medicine inpatient clinical rotation grades.
The SCT will be given to PGY1, 2, and 3 residents each year during the Residents three year residency, in June or July.
Study Type : | Observational |
Estimated Enrollment : | 130 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Do Script Concordance Tests Correlate With Family Medicine Standardized Tests and Failing Rotation Grades? |
Actual Study Start Date : | June 1, 2019 |
Estimated Primary Completion Date : | June 2024 |
Estimated Study Completion Date : | June 2024 |
- SCT scores compared to ITE scores [ Time Frame: year 1 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ITE scores [ Time Frame: year 2 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ITE scores [ Time Frame: year 3 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ABFM scores [ Time Frame: year 1 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ABFM scores [ Time Frame: year 2 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ABFM scores [ Time Frame: year 3 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to family medicine rotation grades [ Time Frame: year 1 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to family medicine rotation grades [ Time Frame: year 2 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to family medicine rotation grades [ Time Frame: year 3 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ACGME milestones. [ Time Frame: year 1 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ACGME milestones. [ Time Frame: year 2 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- SCT scores compared to ACGME milestones. [ Time Frame: year 3 ]SCT scores, ranging from 0 to 100 percent, are longitudinal and will be recorded for all PGY1, 2, and 3 subjects enrolled in the study each year of their residency in June or July.
- Binomial SCT classification derived from each interval SCT scores compared to ACGME milestones. [ Time Frame: year 1 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ACGME milestones. [ Time Frame: year 2 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ACGME milestones. [ Time Frame: year 3 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to family medicine rotation grades. [ Time Frame: year 1 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to family medicine rotation grades. [ Time Frame: year 2 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to family medicine rotation grades. [ Time Frame: year 3 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ITE [ Time Frame: year 1 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ITE [ Time Frame: year 2 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ITE [ Time Frame: year 3 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ABFM [ Time Frame: year 1 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ABFM [ Time Frame: year 2 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".
- Binomial SCT classification derived from each interval SCT scores compared to ABFM [ Time Frame: year 3 ]A "fail" classification is defined as an SCT score 1 SD below the respective PGY mean. All other SCT scores will be classified as "pass".

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
**Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study**
Inclusion Criteria:
--Family Medicine resident at 99MDG
Exclusion Criteria:
-- N/A

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03938610
Contact: Jill M Clark, MBA | 7026533298 | Jill.M.Clark15.ctr@mail.mil |
United States, Nevada | |
Mike O'Callaghan Military Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89191 | |
Contact: Jill M Clark, MBA/HCM 702-653-3298 jill.m.clark15.ctr@mail.mil |
Study Director: | Paul F Crawford, MD | US Air Force |
Documents provided by Pamela Hughes, Mike O'Callaghan Military Hospital:
Publications:
Responsible Party: | Pamela Hughes, Principal Investigator, Mike O'Callaghan Military Hospital |
ClinicalTrials.gov Identifier: | NCT03938610 |
Other Study ID Numbers: |
FWH20190010H |
First Posted: | May 6, 2019 Key Record Dates |
Last Update Posted: | July 23, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | We do not plan on sharing data |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |